Afatinib

Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity. Afatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of selected forms of metastatic non-small cell lung cancer

A Anant Labs fabrica e fornece impurezas de Afatinib de alta qualidade para o mercado global. Nossas impurezas EP de Afatinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.